Revolution Medicines’ new drug for one of the deadliest forms of cancer traces its molecular origins to a University of Illinois chemistry lab. But for the state’s growing biotech sector, it’s another painful “what could have been” story: The company that turned the research into an FDA-approved drug, catching national headlines in the process, is now in California, not Urbana.